Clinical Trials Browser

Non-Squamous Non-small Cell Lung Cancer × Injections × 90 days × Clear all

NCT05184712 2026-03-04

Phase 3 Clinical Study of AK112 for NSCLC Patients

Phase 3 Active not recruiting

Non-Squamous Non-small Cell Lung Cancer